Trial Profile

A Randomized, Double-blind, Placebo-controlled, Multiple-dose Escalation IIT Clinical Study to Evaluate the Efficacy and Safety of Injectable IMC-001 in Patients With Recent Acute Coronary Syndrome (ACS) Who Are Receiving Optimal Medical Therapy After PCI Treatment

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 26 Sep 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

24 Aug 2025 The protocol has been amended to increase in time frame for its primary endpoint and Masking type to double-blind.
24 Aug 2025 Planned number of patients changed from 14 to 30.
24 Aug 2025 Planned End Date changed from 30 Dec 2025 to 30 Jun 2026.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com